Comstra HS, McArthy J, Rudin-Rush S, Hartwig C, Gokhale A, Zlatic SA, Blackburn JB, Werner E, Petris M, DSouza P, Panuwet P, Boyd Barr D, Lupashin V, Vrailas-Mortimer A, Faundez V
Clinical Evidence on Continuous Semaglutide Therapy Research published in major medical journals confirms that ongoing semaglutide use prevents weight regain better than any alternative studied to date
Reese DE, Mikawa T, Bader DM (2002) Development of the coronary vessel system
GLP-1 receptor agonists (like Ozempic, Wegovy, and Rybelsus, which all contain the active ingredient semaglutide) are medications that mimic what natural GLP-1 does, helping support your body when it needs a little extra help
If you want the broader context, our guide to what GLP-1 is is a helpful place to start